Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia

Iron Overload in Human Disease

(2012) Robert E. Fleming et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepcidin: clinical utility as a diagnostic tool and therapeutic target

(2011) Daniel W. Coyne   KIDNEY INTERNATIONAL

Iron deficiency syndromes and iron-restricted erythropoiesis (CME)

(2011) Lawrence Tim Goodnough   TRANSFUSION

The Hepcidin-Ferroportin System as a Therapeutic Target in Anemias and Iron Overload Disorders

(2011) T. Ganz et al.   Hematology-American Society of Hematology Education Program

Hepcidin and Disorders of Iron Metabolism

(2010) Tomas Ganz et al.   Annual Review of Medicine

Detection, evaluation, and management of iron-restricted erythropoiesis

(2010) L. T. Goodnough et al.   BLOOD

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients

(2010) Wajeh Y. Qunibi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The Role of Hepcidin in Iron Metabolism

(2009) Elizabeta Nemeth et al.   ACTA HAEMATOLOGICA

Hepcidin--A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease

(2009) J. Zaritsky et al.   Clinical Journal of the American Society of Nephrology

Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

(2009) Damien R. Ashby et al.   KIDNEY INTERNATIONAL

BLOOD MANAGEMENT: Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial

(2009) David B. Van Wyck et al.   TRANSFUSION

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial

(2008) Stefanie Kulnigg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Iron Deficiency Anemia

(2008) Susan F. Clark   NUTRITION IN CLINICAL PRACTICE